Potency and selectivity of RXP407 on human, rat, and mouse angiotensin-converting enzyme

Biochemical Pharmacology

Volumn 61, Issue 7, 2001, Pages 835-841

  Vazeux, Gille ^a   Cotton, Joël ^a   Cuniasse, Philippe ^a   Dive, Vincent ^a  

^a DIF   (France)

Author keywords

Ac S D K P; ACE; Phosphinic; Zinc metalloproteinase

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG POTENCY; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DRUG INTERACTIONS; GROWTH INHIBITORS; HUMANS; HYDROLYSIS; MALE; MICE; OLIGOPEPTIDES; PEPTIDYL-DIPEPTIDASE A; PHOSPHINIC ACIDS; RATS; SPECIES SPECIFICITY; TESTIS;

EID: 0035313232     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00550-0     Document Type: Article

References (19)

1. Pulmonary and testicular angiotensin-converting isoenzymes
2. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning
3. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active
4. The hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme
5. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline
6. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: Angiotensin-(1-7) and keto-ACE
7. RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites
8. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases
9. Purification of angiotensin-converting enzyme from rabbit lung and plasma by affinity chromatography
10. Affinity chromatographic purification of angiotensin converting enzyme
11. Angiotensin-converting enzyme from human tissues. Physiocochemical, catalytic, and immunological properties
12. Isolation of two differentially glycosylated forms of peptidyl-dipeptidase A (angiotensin converting enzyme) from pig brain: A re-evaluation of their role in neuropeptide metabolism
13. Molecular cloning of human testicular angiotensin-converting enzyme: The testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme
14. A comparison of the zinc contents and substrate specificities of the endothelial and testicular forms of porcine angiotensin converting enzyme and the preparation of isoenzyme-specific antisera
15. The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters
16. The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme
17. Proteins of rat serum: I. Establishing a reference two-dimensional electrophoresis map by immunodetection and microbore high performance liquid chromatography-electrospray mass spectrometry
18. Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSF
19. The tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Goralatide) protects from doxorubicin-induced toxicity: Improvement in mice survival and protection of bone marrow stem cells and progenitors